[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Karim et al., 2017 - Google Patents

Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function

Karim et al., 2017

View PDF @Full View
Document ID
17829785487332457775
Author
Karim A
Reba S
Li Q
Boom W
Rojas R
Publication year
Publication venue
European journal of immunology

External Links

Snippet

We have recently demonstrated that mycobacterial ligands engage Toll like receptor 2 (TLR2) on CD4+ T cells and up‐regulate T‐cell receptor (TCR) triggered Th1 responses in vitro and in vivo. To better understand the role of T‐cell expressed TLR2 on CD4+ T‐cell …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses

Similar Documents

Publication Publication Date Title
Karim et al. Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function
Balin et al. Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria
Van Acker et al. CD56 in the immune system: more than a marker for cytotoxicity?
Do et al. An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell–suppressive function and therapeutic efficacy
Romee et al. Utilizing cytokines to function‐enable human NK cells for the immunotherapy of cancer
Polz et al. Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity
Visekruna et al. Tc9 cells, a new subset of CD8+ T cells, support Th2‐mediated airway inflammation
Maceiras et al. T follicular regulatory cells in mice and men
Gabryšová et al. Integrated T‐cell receptor and costimulatory signals determine TGF‐β‐dependent differentiation and maintenance of Foxp3+ regulatory T cells
Kwan et al. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells
Chang et al. IFN‐γ‐STAT1 signal regulates the differentiation of inducible Treg: Potential role for ROS‐mediated apoptosis
Sakaguchi et al. FOXP3+ regulatory T cells in the human immune system
Ralainirina et al. Control of NK cell functions by CD4+ CD25+ regulatory T cells
Rüter et al. Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
Gallon et al. Differential effects of calcineurin and mammalian target of rapamycin inhibitors on alloreactive Th1, Th17, and regulatory T cells
Schaub et al. Impairment of T helper and T regulatory cell responses at birth
Goodier et al. Lipopolysaccharide stimulates the proliferation of human CD56+ CD3− NK cells: a regulatory role of monocytes and IL-10
Chopp et al. From thymus to tissues and tumors: a review of T-cell biology
Bandaru et al. Phosphorylated STAT3 and PD‐1 regulate IL‐17 production and IL‐23 receptor expression in Mycobacterium tuberculosis infection
Klein et al. F lt3 ligand expands CD 4+ F ox P 3+ regulatory T cells in human subjects
Moreau et al. Transitional‐2 B cells acquire regulatory function during tolerance induction and contribute to allograft survival
Tang et al. B cells promote tumor progression in a mouse model of HPV‐mediated cervical cancer
AU2002257648A1 (en) CD4+CD25+ regulatory T cells from human blood
EP1379625A1 (en) Cd4+cd25+ regulatory t cells from human blood
Rodríguez‐Rodríguez et al. Pro‐inflammatory self‐reactive T cells are found within murine TCR‐αβ+ CD4− CD8− PD‐1+ cells